ALGEMENE BOUWONDERNEMING NELISSEN STEFAN financials
A multi-period view of the public annual-account figures reported for ALGEMENE BOUWONDERNEMING NELISSEN STEFAN, with comparable measures and links to available source documents.
Company overviewRegistry number
0837153946
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jun 30, 2025
Financial evidence
Latest movements for ALGEMENE BOUWONDERNEMING NELISSEN STEFAN
2025 versus 2024
- Operating line
- €32,997
- EBITDA
- €31,613
- Total assets
- €211,125
- Equity
- €122,182
-37.4%
-37.4%
+14.9%
+4.5%
EBITDA margin +95.8% · Equity ratio +57.9%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Jun 2025 | €32,997 | €31,613 | €211,125 | €122,182 | - |
| 202430 Jun 2024 | €52,702 | €50,515 | €183,745 | €116,882 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.